| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children
|
Nasser, Azmi
|
|
|
42 |
8 |
p. 1452-1466
|
artikel
|
| 2 |
Approach to Evaluating QT Prolongation of Quetiapine Fumarate in Late Stage of Clinical Development Using Concentration-QTc Modeling and Simulation in Japanese Patients With Bipolar Disorder
|
Fukushi, Risa
|
|
|
42 |
8 |
p. 1483-1493.e1
|
artikel
|
| 3 |
Assessing Participation Burden in Clinical Trials: Introducing the Patient Friction Coefficient
|
Cameron, David
|
|
|
42 |
8 |
p. e150-e159
|
artikel
|
| 4 |
Assessment of the Regulatory Dialogue Between Pharmaceutical Companies and the European Medicines Agency on the Choice of Noninferiority Margins
|
Althunian, Turki A.
|
|
|
42 |
8 |
p. 1588-1594
|
artikel
|
| 5 |
Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting
|
Peñas-LLedó, Eva
|
|
|
42 |
8 |
p. 1595-1610.e5
|
artikel
|
| 6 |
Clinical Application of Iodine-125 Seed Brachytherapy Combined with Anti–PD-1 Antibodies in the Treatment of Lung Cancer
|
Sui, Aixia
|
|
|
42 |
8 |
p. 1612-1616
|
artikel
|
| 7 |
Conversations With the Editors: Hepatitis C Virus—Where are We Now and Where Do We Go From Here?
|
Trooskin, Stacey
|
|
|
42 |
8 |
p. 1425-1432
|
artikel
|
| 8 |
COVID-19: Regulatory Landscape of Medicinal and Medical Device Products for Human Use
|
Beninger, Paul
|
|
|
42 |
8 |
p. 1444-1450
|
artikel
|
| 9 |
Denosumab Versus Zoledronic Acid in the Prevention of Skeletal-related Events in Vulnerable Cancer Patients: A Meta-analysis of Randomized, Controlled Trials
|
Chen, Chaoyang
|
|
|
42 |
8 |
p. 1494-1507.e1
|
artikel
|
| 10 |
Early Cost-effectiveness Analysis of Electrochemotherapy as a Prospect Treatment Modality for Skin Melanoma
|
Pirc, Eva
|
|
|
42 |
8 |
p. 1535-1548.e2
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
42 |
8 |
p. ii-iii
|
artikel
|
| 12 |
Effect of a Peer-led Lifestyle Intervention on Individuals With Normal Weight Obesity: Insights From the Kerala Diabetes Prevention Program
|
Kapoor, Nitin
|
|
|
42 |
8 |
p. 1618-1624
|
artikel
|
| 13 |
Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison
|
Vidyasagar, Kota
|
|
|
42 |
8 |
p. e115-e139
|
artikel
|
| 14 |
Intravenous Compatibility of Ceftazidime–Avibactam and Aztreonam Using Simulated and Actual Y-site Administration
|
O'Donnell, J. Nicholas
|
|
|
42 |
8 |
p. 1580-1586.e2
|
artikel
|
| 15 |
Open-label, Single-dose Studies of the Pharmacokinetics of Edaravone in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects with Normal Hepatic Functioning
|
Nakamaru, Yoshinobu
|
|
|
42 |
8 |
p. 1467-1482.e4
|
artikel
|
| 16 |
Pharmacokinetic and Pharmacodynamic Analysis of Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Imipenem
|
Li, Zhe
|
|
|
42 |
8 |
p. 1564-1577.e8
|
artikel
|
| 17 |
Pharmacokinetics and Pharmacodynamics of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta in Healthy Subjects: A Randomized, Double-blind Trial
|
Lickliter, Jason
|
|
|
42 |
8 |
p. 1508-1518.e1
|
artikel
|
| 18 |
Safety, Pharmacokinetics, and Pharmacodynamics of the TLR4 Agonist GSK1795091 in Healthy Individuals: Results from a Randomized, Double-blind, Placebo-controlled, Ascending Dose Study
|
Hug, Bruce A.
|
|
|
42 |
8 |
p. 1519-1534.e33
|
artikel
|
| 19 |
Screening for Hepatitis C Virus: How Universal Is Universal?
|
Jhaveri, Ravi
|
|
|
42 |
8 |
p. 1434-1441
|
artikel
|
| 20 |
Table of Contents
|
|
|
|
42 |
8 |
p. iv-v
|
artikel
|
| 21 |
The Unmet Medical Needs of Current Injectable Antidiabetic Therapies in China: Patient and Health Care Professional Perspectives
|
Chen, Taixiong
|
|
|
42 |
8 |
p. 1549-1563
|
artikel
|
| 22 |
Variation in Plasma Levels of Glucosamine With Chronic Dosing: A Possible Reason for Inconsistent Clinical Outcomes in Osteoarthritis
|
Asthana, Chhavi
|
|
|
42 |
8 |
p. e140-e149
|
artikel
|
Tijdschrift beschrijving